SCHEMBL3264452

SCHEMBL3264452

O=C(O)C1CC=CC2CCN(Cc3ccc(Cl)c(Cl)c3)C(=O)C21

nearest known ligand 0.78

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.78
▸ HCRTR1 O43613 2/20 0.76
▸ OPRK1 P41145 2/20 0.57
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ PREP P48147 3/20 0.48
▸ SIGMAR1 Q99720 1/20 0.39
▸ S1PR5 Q9H228 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13108370 1.00 ALDH1A1 (0.78) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13099472 1.00 ALDH1A1 (0.78) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL15978272 1.00 ALDH1A1 (0.78) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13108582 1.00 ALDH1A1 (0.78) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13108369 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13099474 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13099475 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13108375 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL13099473 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A
SCHEMBL3107219 0.88 ALDH1A1 (1.00) ALDH1A1HCRTR1OPRK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010037050-A2 SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS UNIVERSITY OF KANSAS (US) 2010-04-01 — — WO disclosed
Send feedback